MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
MCE 國際站:Mal-PEG2-VCP-Eribulin
品牌:MedChemExpress (MCE)
CAS:2130869-18-8
純度:0.9982
貨號(hào):HY-128870
存儲(chǔ)條件:-20°C,避光,氮?dú)獗4?*溶劑中:-80°C,6 個(gè)月;-20°C,1 個(gè)月(避光,氮?dú)獗4妫?/p>
運(yùn)輸條件:美國大陸的室溫;其他地方可能有所不同。
產(chǎn)品活性:Mal-PEG2-VCP-Eribulin 由 ADC linker (Mal-PEG2-VCP) 和 Eribulin (HY-13442) 偶聯(lián)而成。Eribulin 是一種特別的微管 (microtubule) 抑制劑,通過結(jié)合微管蛋白和微管來抑制癌細(xì)胞的增殖。Mal-PEG2-VCP-Eribulin 是一種基于 Eribulin 的抗體偶聯(lián)劑。
IC50 & Target:Traditional Cytotoxic Agents
熱銷產(chǎn)品:Pentagastrin | Lupeol | Clopidogrel (hydrogen sulfate) | Hinokiflavone | Risdiplam | PD150606 | 3-Pyridineacetic acid | Zidovudine | Tadalafil | Monomethyl fumarate
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
參考文獻(xiàn):
[1]. Earl F Albone, et al. Eribulin-based antibody-drug conjugates and methods of use. US20170252458A1.
[2]. Towle MJ, et al. Eribulin induces irreversible mitotic blockade: implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions. Cancer Res. 2011 Jan 15;71(2):496-505.
[3]. Watanabe K, et al. Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo. Oncotarget. 2019 Jan 4;10(2):161-174.
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)
立即詢價(jià)
您提交后,專屬客服將第一時(shí)間為您服務(wù)